ApoWiser Overview
ApoWiser is the developer of PharmAssist and VitAssist, solutions designed to help people self-treat mild ailments and educate themselves about possible deficiencies in vitamins, minerals, and supplements. ApoWiser serves consumers at Israel’s largest pharmacy chain (Super-Pharm) and the second-largest HMO (Maccabi) through their channels. ApoWiser is focused on enabling retailers to expand and better serve their customers by introducing them to products beyond the retailers’ existing channels.
Cumulative Funding Raised Over Time ($)
$1.5MApr 2022
Latest News
growth-positive
Apowiser Raises $1.5M In Seed Funding from Longliv Ventures, a Member of CK Hutchison Holdings, to Expand the Global Reach of its Novel Digital Platform that Empowers Consumers to make Informed Choices when Selecting Over-the-Counter Medications
Israeli start-up Apowiser has raised $1.5 million in a seed funding round led by Longliv Ventures. The company has developed PharmAssist, a chatbot-based system that supports customers in the online purchase of Over-the-Counter (OTC) drugs. PharmAssist is a digital online platform that allows consumers to learn more about their condition, check for allergies, and purchase the appropriate OTC product. The platform covers more than 600 OTC drugs and complimentary products. Apowisers offering has proven to be an essential tool for consumers and pharmacies, with Super-Pharm already using PharmAssist and seeing increased conversion rates. Longliv Ventures is a member of CK Hutchinson Holdings Limited.
Investment
growth-positive
סופר-פארם משיקה בוט לתרופות ללא מרשם - וואלה! כסף
Super-Pharm, a leading pharmacy chain in Israel, has launched a new tool called PharmAssist. This tool helps customers remotely locate the most suitable over-the-counter (OTC) drugs for their condition, in a quick and efficient manner. The system was developed by Apowiser, a company founded by Professor Ilan Schwartzberg, former director of the Pharmacy Department at the Ministry of Health. The tool guides the user through basic questions, maintaining privacy, and then asks further questions about the users complaint, allowing them to choose from a variety of common conditions.
CustomersExpand
| Sector | Business Software |
Funding
| Total funding | $1.5M |
| Last funding | $1.5M |
| Stage | Seed |
| Rounds | 1 |
| Investors | 1 |
Team Members
4
Employees: 1-10
Web & Social Links
| Website | apowiser.com/ |
Locations
Zarhin St 13, Ra'anana, Israel
Photos & Videos
1 item(s)
ApoWiser Business
Business models
B2B
Product stage
Released
Employees
1-10
Sector
Health Tech & Life SciencesDigital HealthcarePatient EngagementBusiness SoftwareSales & Marketing Solutionse-Commerce ToolsTarget Customer
Healthcare & Life SciencesLife SciencesPharmaceuticalsCore Technology
Platforms & InterfacesWebArtificial IntelligenceChatbotsTags (10)
virtual-assistantpersonalizationweb-platformdecision-supportchatbotpharmaceuticalsdigital-healthcarecrowdsourcingartificial-intelligencesocial-commerceApoWiser Financials
$1.5M
Total funding
Undisclosed
Capital raised
$1.5M
Last funding
Seed
Funding stage
1
Total rounds
1
Investors
Cumulative Funding Raised Over Time ($)
$1.5MApr 2022
Private Equity Funding
Seed
Apr 2022
$1.5M
Longliv Ventures
ApoWiser Lifecycle
Cumulative Funding Raised Over Time
$1.5MApr 2022
All Events
Seed
Apr 2022
$1.5M
Longliv Ventures
ApoWiser News
2 articles
growth-positive
Apowiser Raises $1.5M In Seed Funding from Longliv Ventures, a Member of CK Hutchison Holdings, to Expand the Global Reach of its Novel Digital Platform that Empowers Consumers to make Informed Choices when Selecting Over-the-Counter Medications
Israeli start-up Apowiser has raised $1.5 million in a seed funding round led by Longliv Ventures. The company has developed PharmAssist, a chatbot-based system that supports customers in the online purchase of Over-the-Counter (OTC) drugs. PharmAssist is a digital online platform that allows consumers to learn more about their condition, check for allergies, and purchase the appropriate OTC product. The platform covers more than 600 OTC drugs and complimentary products. Apowisers offering has proven to be an essential tool for consumers and pharmacies, with Super-Pharm already using PharmAssist and seeing increased conversion rates. Longliv Ventures is a member of CK Hutchinson Holdings Limited.
Investment
growth-positive
סופר-פארם משיקה בוט לתרופות ללא מרשם - וואלה! כסף
Super-Pharm, a leading pharmacy chain in Israel, has launched a new tool called PharmAssist. This tool helps customers remotely locate the most suitable over-the-counter (OTC) drugs for their condition, in a quick and efficient manner. The system was developed by Apowiser, a company founded by Professor Ilan Schwartzberg, former director of the Pharmacy Department at the Ministry of Health. The tool guides the user through basic questions, maintaining privacy, and then asks further questions about the users complaint, allowing them to choose from a variety of common conditions.
CustomersExpand
ApoWiser Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 5 |
| Team members | 4 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 14 classification IDs that could be used for matching.
ApoWiser Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 93/100 |
| Missing | markets, not claimed |
| BI Verification | Yanina Wainscheinker |
| Registrar ID | 516322161 |
| Crunchbase | apowiser |
| Creator | Jenny Sotnik-Talisman |
| Creator email | genys30@yahoo.com |
| Last updater | Jenny Sotnik-Talisman |
| Updater email | jenny.sotnik@sncentral.org |
| Last update | 2022-09-22T00:00:00.000Z |
| Created | 2021-05-19T00:00:00.000Z |
| Claimed | Yes |